mDETECT Inc.
Kingston, CA · 2 known investors
mDETECT develops methylation- and NGS-based liquid biopsy tests to monitor metastatic cancer, aimed at clinical validation and commercial diagnostic use. The company's work centers on tracking disease in patients battling metastatic cancer.
Founders & leadership
CM
Christopher MuellerPresident and CEO
IW
Irsa WigintonBusiness Development Officer
KF
Keira FrosstScientific Officer
Investors · 2
Frequently asked questions
- What does mDETECT Inc. do?
- mDETECT develops methylation- and NGS-based liquid biopsy tests to monitor metastatic cancer, aimed at clinical validation and commercial diagnostic use. The company's work centers on tracking disease in patients battling metastatic cancer.
- Who are mDETECT Inc.'s investors?
- mDETECT Inc.'s investors include Ontario Centre of Innovation, Ontario Centre of Innovation programs.
- Where is mDETECT Inc. headquartered?
- mDETECT Inc. is headquartered in Kingston, CA.